West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services Dividend Announcement
• West Pharmaceutical Services announced a quarterly dividend of $0.21 per ordinary share which will be made payable on 2024-11-20. Ex dividend date: 2024-11-13
• West Pharmaceutical Services annual dividend for 2024 was $0.81
• West Pharmaceutical Services annual dividend for 2023 was $0.77
• West Pharmaceutical Services's trailing twelve-month (TTM) dividend yield is 0.25%
• West Pharmaceutical Services's payout ratio for the trailing twelve months (TTM) is 11.73%
• West Pharmaceutical Services's dividend growth over the last five years (2018-2023) was 6.20% year
• West Pharmaceutical Services's dividend growth over the last ten years (2013-2023) was 1.40% year
West Pharmaceutical Services Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-13 | $0.21 | quarterly | 2024-11-20 |
2024-07-31 | $0.20 | quarterly | 2024-08-07 |
2024-04-23 | $0.20 | quarterly | 2024-05-01 |
2024-01-30 | $0.20 | quarterly | 2024-02-07 |
2023-11-07 | $0.20 | quarterly | 2023-11-15 |
2023-07-25 | $0.19 | quarterly | 2023-08-02 |
2023-04-25 | $0.19 | quarterly | 2023-05-03 |
2023-01-24 | $0.19 | quarterly | 2023-02-01 |
2022-11-08 | $0.19 | quarterly | 2022-11-16 |
2022-07-19 | $0.18 | quarterly | 2022-08-03 |
2022-04-19 | $0.18 | quarterly | 2022-05-04 |
2022-01-18 | $0.18 | quarterly | 2022-02-02 |
2021-11-09 | $0.18 | quarterly | 2021-11-17 |
2021-07-20 | $0.17 | quarterly | 2021-08-04 |
2021-04-20 | $0.17 | quarterly | 2021-05-05 |
2021-01-19 | $0.17 | quarterly | 2021-02-03 |
2020-11-09 | $0.17 | quarterly | 2020-11-18 |
2020-07-28 | $0.16 | quarterly | 2020-08-05 |
2020-04-21 | $0.16 | quarterly | 2020-05-06 |
2020-01-21 | $0.16 | quarterly | 2020-02-05 |
2019-10-22 | $0.16 | quarterly | 2019-11-06 |
2019-07-23 | $0.15 | quarterly | 2019-08-07 |
2019-04-16 | $0.15 | quarterly | 2019-05-01 |
2019-01-22 | $0.15 | quarterly | 2019-02-06 |
2018-10-23 | $0.15 | quarterly | 2018-11-07 |
2018-07-17 | $0.14 | quarterly | 2018-08-01 |
2018-04-17 | $0.14 | quarterly | 2018-05-02 |
2018-01-17 | $0.14 | quarterly | 2018-02-01 |
2017-10-17 | $0.14 | quarterly | 2017-11-01 |
2017-07-17 | $0.13 | quarterly | 2017-08-02 |
2017-04-17 | $0.13 | quarterly | 2017-05-03 |
2017-01-13 | $0.13 | quarterly | 2017-02-01 |
2016-10-17 | $0.13 | quarterly | 2016-11-02 |
2016-07-18 | $0.12 | quarterly | 2016-08-03 |
2016-04-18 | $0.12 | quarterly | 2016-05-04 |
2016-01-15 | $0.12 | quarterly | 2016-02-03 |
2015-10-19 | $0.12 | quarterly | 2015-11-04 |
2015-07-20 | $0.11 | quarterly | 2015-08-05 |
2015-04-20 | $0.11 | quarterly | 2015-05-06 |
2015-01-16 | $0.11 | quarterly | 2015-02-04 |
2014-10-20 | $0.11 | quarterly | 2014-11-05 |
2014-07-21 | $0.10 | quarterly | 2014-08-06 |
2014-04-21 | $0.10 | quarterly | 2014-05-07 |
2014-01-17 | $0.10 | quarterly | 2014-02-05 |
2013-10-21 | $0.10 | quarterly | 2013-11-06 |
2013-07-22 | $0.19 | quarterly | 2013-08-07 |
2013-04-15 | $0.19 | quarterly | 2013-05-01 |
2013-01-18 | $0.19 | quarterly | 2013-02-06 |
West Pharmaceutical Services Dividend per year
West Pharmaceutical Services Dividend growth
West Pharmaceutical Services Dividend Yield
West Pharmaceutical Services current trailing twelve-month (TTM) dividend yield is 0.25%. Interested in purchasing West Pharmaceutical Services stock? Use our calculator to estimate your expected dividend yield:
West Pharmaceutical Services Financial Ratios
West Pharmaceutical Services Dividend FAQ
Other factors to consider when evaluating West Pharmaceutical Services as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy West Pharmaceutical Services stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: West Pharmaceutical Services's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, West Pharmaceutical Services publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, West Pharmaceutical Services distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from West Pharmaceutical Services are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: West Pharmaceutical Services sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, West Pharmaceutical Services distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: West Pharmaceutical Services declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of West Pharmaceutical Services's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review West Pharmaceutical Services's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.